Lawrence Otto Klein is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 24,500 shares of JSPR, which is worth approximately $542,675. The most recent transaction as insider was on Oct 12, 2022, when has been sold 24,500 shares (Voting Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.5K
0% 3M change
0% 12M change
Total Value Held $542,675

Lawrence Otto Klein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2022
BUY
Grant, award, or other acquisition
-
24,500 Added 50.0%
24,500 Voting Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
DYN
Dyne Therapeutics, Inc. Healthcare
LOK

Lawrence Otto Klein

Director
Cambridge, MA

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR